Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -4.97% | 136.25 | 0.0% | $893.93m | |
| AMGN | Amgen, Inc. | 1.12% | 247.50 | 1.5% | $828.95m | |
| GILD | Gilead Sciences, Inc. | 0.90% | 63.84 | 1.0% | $542.01m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.23% | 258.59 | 1.9% | $461.95m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.61% | 661.14 | 2.6% | $422.10m | |
| ILMN | Illumina, Inc. | 1.14% | 243.49 | 3.3% | $313.80m | |
| NVAX | Novavax, Inc. | -8.57% | 53.42 | 75.7% | $307.51m | |
| BIIB | Biogen, Inc. | 3.40% | 199.65 | 1.8% | $240.05m | |
| BNTX | BioNTech SE | -2.90% | 163.00 | 0.0% | $226.41m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 1.93% | 2.11 | 0.7% | $147.50m | |
| EXAS | EXACT Sciences Corp. | -1.54% | 53.17 | 17.7% | $147.09m | |
| TXG | 10X Genomics, Inc. | 0.58% | 50.16 | 0.0% | $101.29m | |
| TECH | Bio-Techne Corp. | -0.03% | 366.35 | 4.5% | $100.80m | |
| NKTX | Nkarta, Inc. | -1.78% | 12.67 | 0.0% | $99.26m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.56% | 79.72 | 4.2% | $98.40m |
Company Profile
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.